vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and Strategy Inc (MSTR). Click either name above to swap in a different company.

Strategy Inc is the larger business by last-quarter revenue ($123.0M vs $121.8M, roughly 1.0× Core Laboratories Inc.). On growth, Strategy Inc posted the faster year-over-year revenue change (1.9% vs -1.4%). Over the past eight quarters, Strategy Inc's revenue compounded faster (3.3% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Strategy Inc., formerly known as MicroStrategy, is an American company that provides business intelligence (BI) and mobile software. Founded in 1989 by Michael J. Saylor, Sanju Bansal, and Thomas Spahr, the firm develops software to analyze internal and external data in order to make business decisions and to develop mobile apps. It is a public company headquartered in Tysons Corner, Virginia, in the Washington metropolitan area. Its primary business analytics competitors include SAP SE Busin...

CLB vs MSTR — Head-to-Head

Bigger by revenue
MSTR
MSTR
1.0× larger
MSTR
$123.0M
$121.8M
CLB
Growing faster (revenue YoY)
MSTR
MSTR
+3.3% gap
MSTR
1.9%
-1.4%
CLB
Faster 2-yr revenue CAGR
MSTR
MSTR
Annualised
MSTR
3.3%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
CLB
CLB
MSTR
MSTR
Revenue
$121.8M
$123.0M
Net Profit
$5.1M
Gross Margin
66.1%
Operating Margin
1.5%
Net Margin
4.2%
Revenue YoY
-1.4%
1.9%
Net Profit YoY
EPS (diluted)
$0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
MSTR
MSTR
Q1 26
$121.8M
Q4 25
$138.3M
$123.0M
Q3 25
$134.5M
$128.7M
Q2 25
$130.2M
$114.5M
Q1 25
$123.6M
$111.1M
Q4 24
$129.2M
$120.7M
Q3 24
$134.4M
$116.1M
Q2 24
$130.6M
$111.4M
Net Profit
CLB
CLB
MSTR
MSTR
Q1 26
$5.1M
Q4 25
$4.9M
Q3 25
$14.2M
$2.8B
Q2 25
$10.6M
$10.0B
Q1 25
$-154.0K
$-4.2B
Q4 24
$7.4M
$-670.8M
Q3 24
$11.7M
$-340.2M
Q2 24
$9.0M
$-102.6M
Gross Margin
CLB
CLB
MSTR
MSTR
Q1 26
Q4 25
20.8%
66.1%
Q3 25
22.0%
70.5%
Q2 25
20.3%
68.8%
Q1 25
19.5%
69.4%
Q4 24
17.8%
71.7%
Q3 24
20.5%
70.4%
Q2 24
21.2%
72.2%
Operating Margin
CLB
CLB
MSTR
MSTR
Q1 26
1.5%
Q4 25
11.5%
Q3 25
15.6%
Q2 25
11.7%
Q1 25
3.6%
-5331.4%
Q4 24
11.0%
-842.1%
Q3 24
14.7%
-372.7%
Q2 24
12.3%
-179.7%
Net Margin
CLB
CLB
MSTR
MSTR
Q1 26
4.2%
Q4 25
3.6%
Q3 25
10.6%
2164.1%
Q2 25
8.2%
8752.7%
Q1 25
-0.1%
-3797.2%
Q4 24
5.7%
-555.8%
Q3 24
8.7%
-293.1%
Q2 24
6.9%
-92.0%
EPS (diluted)
CLB
CLB
MSTR
MSTR
Q1 26
$0.11
Q4 25
$0.11
Q3 25
$0.30
$8.42
Q2 25
$0.22
$32.60
Q1 25
$0.00
$-16.49
Q4 24
$0.15
$4.49
Q3 24
$0.25
$-1.72
Q2 24
$0.19
$-0.57

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
MSTR
MSTR
Cash + ST InvestmentsLiquidity on hand
$22.8M
$2.3B
Total DebtLower is stronger
$8.2B
Stockholders' EquityBook value
$275.1M
$44.1B
Total Assets
$587.7M
$61.6B
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
MSTR
MSTR
Q1 26
$22.8M
Q4 25
$22.7M
$2.3B
Q3 25
$25.6M
$54.3M
Q2 25
$31.2M
$50.1M
Q1 25
$22.1M
$60.3M
Q4 24
$19.2M
$38.1M
Q3 24
$21.5M
$46.3M
Q2 24
$17.7M
$66.9M
Total Debt
CLB
CLB
MSTR
MSTR
Q1 26
Q4 25
$110.3M
$8.2B
Q3 25
$114.1M
$8.2B
Q2 25
$124.6M
$8.2B
Q1 25
$124.4M
$8.1B
Q4 24
$126.1M
$7.2B
Q3 24
$139.9M
$4.2B
Q2 24
$147.6M
$3.8B
Stockholders' Equity
CLB
CLB
MSTR
MSTR
Q1 26
$275.1M
Q4 25
$266.0M
$44.1B
Q3 25
$271.3M
$52.3B
Q2 25
$261.3M
$47.5B
Q1 25
$253.4M
$32.2B
Q4 24
$246.6M
$18.2B
Q3 24
$250.7M
$3.8B
Q2 24
$240.3M
$2.8B
Total Assets
CLB
CLB
MSTR
MSTR
Q1 26
$587.7M
Q4 25
$584.0M
$61.6B
Q3 25
$591.4M
$73.6B
Q2 25
$602.1M
$64.8B
Q1 25
$591.5M
$43.9B
Q4 24
$585.1M
$25.8B
Q3 24
$600.5M
$8.3B
Q2 24
$597.8M
$7.1B
Debt / Equity
CLB
CLB
MSTR
MSTR
Q1 26
Q4 25
0.41×
0.19×
Q3 25
0.42×
0.16×
Q2 25
0.48×
0.17×
Q1 25
0.49×
0.25×
Q4 24
0.51×
0.39×
Q3 24
0.56×
1.12×
Q2 24
0.61×
1.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
MSTR
MSTR
Operating Cash FlowLast quarter
$4.0M
Free Cash FlowOCF − Capex
$517.0K
FCF MarginFCF / Revenue
0.4%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$22.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
MSTR
MSTR
Q1 26
$4.0M
Q4 25
$7.9M
Q3 25
$8.5M
$-8.3M
Q2 25
$13.9M
$-34.9M
Q1 25
$6.7M
$-2.4M
Q4 24
$20.6M
$-17.3M
Q3 24
$13.1M
$-41.0M
Q2 24
$17.1M
$-23.3M
Free Cash Flow
CLB
CLB
MSTR
MSTR
Q1 26
$517.0K
Q4 25
$5.0M
Q3 25
$6.5M
$-11.1M
Q2 25
$10.4M
$-37.0M
Q1 25
$3.9M
$-5.1M
Q4 24
$17.4M
$-17.6M
Q3 24
$10.4M
$-41.4M
Q2 24
$14.3M
$-24.1M
FCF Margin
CLB
CLB
MSTR
MSTR
Q1 26
0.4%
Q4 25
3.6%
Q3 25
4.8%
-8.6%
Q2 25
8.0%
-32.3%
Q1 25
3.1%
-4.6%
Q4 24
13.4%
-14.6%
Q3 24
7.7%
-35.7%
Q2 24
10.9%
-21.6%
Capex Intensity
CLB
CLB
MSTR
MSTR
Q1 26
Q4 25
2.1%
Q3 25
1.5%
2.2%
Q2 25
2.7%
1.8%
Q1 25
2.3%
2.5%
Q4 24
2.5%
0.2%
Q3 24
2.0%
0.4%
Q2 24
2.2%
0.6%
Cash Conversion
CLB
CLB
MSTR
MSTR
Q1 26
0.77×
Q4 25
1.61×
Q3 25
0.60×
-0.00×
Q2 25
1.31×
-0.00×
Q1 25
Q4 24
2.78×
Q3 24
1.12×
Q2 24
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons